Kisspeptin
The upstream regulator of reproductive hormone release, in genuine academic clinical trials for fertility and desire disorders; not approved anywhere.
What it is
Kisspeptin is the master upstream switch of reproductive hormone signaling — the brain peptide that tells the whole gonadal axis to run. It's the subject of genuine, ongoing academic clinical research for fertility and desire disorders, and of premature gray-market bottling.
Human studies — largely from academic endocrinology groups — have tested kisspeptin for triggering egg maturation in IVF and for hypoactive sexual desire, with promising early results. No approved product exists anywhere yet.
What researchers have actually studied it for
Reproductive-axis physiology, IVF trigger protocols and hypoactive sexual desire — in genuine academic human trials; not approved anywhere.
How it works
Kisspeptin neurons in the hypothalamus drive GnRH release, which drives LH and FSH, which drive the gonads — it sits at the very top of the reproductive cascade. That upstream position is why researchers find it elegant: it works through, not around, the body's own feedback loops.
Where it came from
Discovered in 1996 in Hershey, Pennsylvania — named 'kisspeptin' after the town's Kisses — it was first known as a metastasis suppressor before 2003 genetics revealed its reproductive role: people with broken kisspeptin receptors don't enter puberty. Academic trials in IVF and desire disorders followed through the 2010s–2020s.
What the research record actually contains
- Human physiology studies establishing its role at the top of the reproductive axis.
- IVF trials using kisspeptin-54 to trigger oocyte maturation with lower hyperstimulation risk.
- Small controlled studies in hypoactive sexual desire with encouraging brain-imaging and behavioral signals.
- No phase 3 program completed; no approval.
What's known about risks
Well tolerated in short academic studies. Chronic-use safety is unstudied, and hormonal-axis stimulation is not a casual self-experiment — the same feedback elegance that interests researchers demands supervision.
Where it stands legally
Investigational everywhere; online 'kisspeptin' is unregulated research-chemical territory.
Worth asking a licensed provider
- 1.For fertility or desire concerns, what's the evaluated pathway before an investigational hormone?
- 2.Is any academic kisspeptin trial recruiting patients like me?
- 3.What baseline hormonal work-up does my situation actually call for?